- Coronary Sinus Reducer Implantation in Patients With Ischaemia and Non-obstructed Coronary Arteries and Coronary Microvascular Dysfunction. — Active Not Recruiting • Non-phase study • Cardiology / Cardiovascular • NCT05492110.
- A device inserted into the coronary sinus improves blood flow and symptoms in patients with chest pain despite normal coronary arteries.
Verify eligibility, endpoints and current status on the original ClinicalTrials.gov registry before acting on this summary.
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
To demonstrate the feasibility and efficacy of the CS Reducer for the treatment of patients with ischaemia and non-obstructed coronary arteries (INOCA) and coronary microvascular dysfunction (CMD) and through a nested mechanistic substudy investigate the physiological responses in the coronary microcirculation responsible for changes in myocardial perfusion. Conditions: Refractory Angina, Microvascular Angina, Microvascular Coronary Artery Disease, Coronary Disease, Angina Pectoris, INOCA (Ischemia With Non Obstructive Coronary Artery Disease), ANOCA - Angina With Non-obstructive Coronary Arteries, Coronary Microvascular Dysfunction (CMD) Interventions: Coronary sinus reducer, Sham Procedure, Invasive coronary physiology Lead Sponsor:…